Summary of half-maximal inhibitory concentration (IC50) and Hill slope values in HEK cells stably expressing human Cav2.1 or Cav2.3c channels and transiently coexpressing GABABRs
| Agonist | Cav2.1 and GABABR | Cav2.3c and GABABR | ||
| IC50 | Hill slope | IC50 | Hill slope | |
| nM | nM | |||
| Baclofen | 470 ± 34 (5) | 0.73 ± 0.05 | 330 ± 72 (7) | 0.75 ± 0.14 |
| GABA | 388 ± 17 (4) | 0.76 ± 0.20 | 328 ± 102 (4) | 0.75 ± 0.24 |
| c-Vc1.1 | — | — | 0.29 ± 0.08 (4–7)a | 0.61 ± 0.14 |
| Agonist | Cav2.1 and GABABR | Cav2.3c and GABABR | ||
| IC50 | Hill slope | IC50 | Hill slope | |
| nM | nM | |||
| Baclofen | 470 ± 34 (5) | 0.73 ± 0.05 | 330 ± 72 (7) | 0.75 ± 0.14 |
| GABA | 388 ± 17 (4) | 0.76 ± 0.20 | 328 ± 102 (4) | 0.75 ± 0.24 |
| c-Vc1.1 | — | — | 0.29 ± 0.08 (4–7)a | 0.61 ± 0.14 |
Values represent mean ± SEM; n, number of experiments in parentheses; see details of the fitting procedure in Materials and methods.
Each data point (Fig. 2 F) was obtained from four to seven individual experiments.